Regencell Bioscience Holdings Limited Ordinary Shares (RGC) is a publicly traded Healthcare sector company. As of May 21, 2026, RGC trades at $27.39 with a market cap of $13.74B and a P/E ratio of 38.67. RGC moved +3.31% today. Year to date, RGC is +1.29%; over the trailing twelve months it is +131.52%. Its 52-week range spans $0.09 to $83.60. Rallies surfaces RGC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for RGC combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $27.39 |
| Market Cap | $13.74B |
| P/E Ratio | 38.67 |
| EPS | $0.72 |
| Dividend Yield | 0.22% |
| 52-Week High | $83.60 |
| 52-Week Low | $0.09 |
| Volume | 90 |
| Avg Volume | 0 |
| Revenue (TTM) | $3.16B |
| Net Income | $112.30M |
| Gross Margin | 0.00% |
RGC analyst coverage data. Average price target: $0.00.